RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile

Por Heidenreich, Regina, Mehr, Keyvan Tadjalli, Noth, Janine, Koch, Sven, Hong, Henoch, Melber, Karl, Daehling, Angelika, Roos, Tilmann, Lutz, Johannes, Kowalczyk, Aleksandra, Baumhof, Patrick, Scheel, Birgit, Voss, Söhnke, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Gnad-Vogt, Ulrike
Publicado no J Immunother Cancer (2015)